SAN DIEGO, July 23, 2020 /PRNewswire/ -- Evofem
Biosciences, Inc. (NASDAQ: EVFM) will hold a webcast and conference
call to discuss the Company's financial results and business
highlights for the second quarter ended June
30, 2020.
|
Date
|
Tuesday, August 4,
2020
|
|
Time
|
11:00 a.m. EDT (8:00
a.m. PDT)
|
|
Dial-in
numbers
|
(866) 503-5561 (U.S.
toll-free) or (253) 336-2965
|
|
Conference
ID
|
5884198
|
|
Webcast (live and
archived)
|
www.evofem.com under
"Investors" or click here
|
The live webcast and related slide presentation can be accessed
on the Company's Investor page at
https://evofem.investorroom.com/events. Please connect to the
Company's website at least 15 minutes prior to the start of the
call to download any software that may be required. If
participating by phone, please dial in approximately 10 minutes
prior to the start of the call.
A telephone replay will be available approximately two hours
after the call through Friday, August 7, 2020 at (855)
859-2056 (U.S.) or (404) 537-3406 (International), conference
ID 5884198. The webcast will be archived at
https://evofem.investorroom.com/events.
About Evofem Biosciences, Inc.
Evofem Biosciences,
Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical
company committed to developing and commercializing innovative
products to address unmet needs in women's sexual and reproductive
health, including hormone-free, woman-controlled contraception and
protection from certain sexually transmitted infections (STIs). The
Company's first commercial product, Phexxi™ (lactic acid, citric
acid and potassium bitartrate), is the first and only vaginal pH
regulator approved in the United States for the
prevention of pregnancy. The Company is also advancing EVO100 into
Phase 3 clinical trials for the prevention of urogenital
transmission of both Chlamydia
trachomatis infection (chlamydia) and Neisseria
gonorrhoeae infection (gonorrhea) in women.
Contact
Investor Relations
Amy Raskopf
Evofem Biosciences
araskopf@evofem.com
O: (858) 550-1900 x167
M: (917) 673-5775
Media
Cara Miller
Evofem Biosciences
cmiller@evofem.com
O: (858) 550-1900 x272
View original content to download
multimedia:http://www.prnewswire.com/news-releases/evofem-biosciences-to-report-second-quarter-2020-results-and-provide-corporate-update-on-tuesday-august-4-2020-301098441.html
SOURCE Evofem Biosciences, Inc.